title: Macrophages from inflamed but not normal glomeruli are unresponsive to anti-inflammatory cytokines.
abstract: This study examined the properties and responsiveness to cytokines of macrophages purified from normal and nephritic glomeruli to ascertain whether macrophages activated in vivo develop programmed unresponsiveness to cytokines as do bone marrow-derived macrophages in vitro when activated by interferon-gamma (IFN-gamma), tumor necrosis factor (TNF), interleukin-4 (IL-4), or transforming growth factor-beta (TGF-beta). Macrophages from normal glomeruli did not generate nitric oxide (NO) spontaneously but only after treatment with IFN-gamma and TNF-alpha. NO generation by these macrophages was abrogated by administering IL-4, TGF-beta, or TNF-alpha before but not after IFN-gamma treatment. Glomerular macrophages also expressed beta-glucuronidase, which was increased by TGF-beta and decreased by IFN-gamma and TNF. By contrast, glomerular macrophages from rats with nephrotoxic nephritis did not express beta-glucuronidase even after exposure to TGF-beta. Furthermore, they generated NO spontaneously, and this spontaneous generation of NO was not suppressed by IL-4, TGF-beta, or TNF-alpha. Systemic treatment of nephritic rats with IL-4 reduced NO generation by 40% but did not prevent activation, which is similar to the effect of IL-4 on bone marrow-derived macrophages in vitro when given simultaneously with IFN-gamma. We conclude that macrophages infiltrating inflamed glomeruli have developed programmed unresponsiveness to activating cytokines. This may enable them to function appropriately in the complex conditions within an inflammatory focus.
authors.affiliation: Department of Medicine and Therapeutics, University of Aberdeen, Aberdeen, United Kingdom. L.P.Erwig@abdn.ac.uk
authors.forename: L P
authors.initials: LP
authors.lastname: Erwig
authors.forename: K
authors.initials: K
authors.lastname: Stewart
authors.forename: A J
authors.initials: AJ
authors.lastname: Rees
mesh_terms: D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D016207:Cytokines / Q000494:pharmacology*; D005966:Glucuronidase / Q000378:metabolism; D007267:Injections; D015847:Interleukin-4 / Q000494:pharmacology; D007678:Kidney Glomerulus / Q000187:drug effects* / Q000473:pathology; D008264:Macrophages / Q000187:drug effects* / Q000201:enzymology / Q000502:physiology; D008297:Male; D009393:Nephritis / Q000473:pathology / Q000503:physiopathology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D011994:Recombinant Proteins; D012016:Reference Values
chemical_list: D000893:Anti-Inflammatory Agents; D016207:Cytokines; D011994:Recombinant Proteins; D015847:Interleukin-4; D005966:Glucuronidase